Home
Research
People
- Investigators
- Instructors
Education
Publications
Units
- Clinical Trials Unit
- Tissue Technologies Unit
News, Events, Calendar
- News & Events
- Calendar
Contact
Search
Menu Menu

A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent

2021-02-28/in Seaman

Xiao T, Lu J, Zhang J, Johnson RI, McKay LGA, Storm N, Lavine CL, Peng H, Cai Y, Rits-Volloch S, Lu S, Quinlan BD, Farzan M, Seaman MS, Griffiths A, Chen B. A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent. Nat Struct Mol Biol. 2021 Feb;28(2):202-209. doi: 10.1038/s41594-020-00549-3. Epub 2021 Jan 11. PMID: 33432247; PMCID: PMC7895301.

Share this entry

Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share by Mail

https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.png 0 0 Morgana Souza https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.png Morgana Souza2021-02-28 14:38:382021-04-03 14:52:54A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent

Prinicpal Investigators

Malika Aid-Boudries, Ph.D.

Dan H. Barouch, M.D., Ph.D.

Ai-ris Yonekura Collier, M.D.

Alan N. Engelman, Ph.D.

Jonathan Gootenberg

Sizun Jiang,Ph.D.

Boris Juelg, M.D., Ph.D.

R. Keith Reeves, Ph.D.

Sampa Santra, Ph.D.

Joern E. Schmitz, M.D.

Michael Seaman, Ph.D.

Omar K. Siddiqi, M.D., M.P.H.

Kathryn E. Stephenson, M.D., M.P.H.

Center for Virology and Vaccine Research

3 Blackfan Circle
Boston, MA 02115 – USA

T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu

CVVR Clinical Trials Unit

T 617.735.4610
E CVVRtrials@bidmc.harvard.edu

Affiliates

Beth Israel Deaconess Medical Center

Harvard University School of Medicine

Participate in Clinical Studies

© Copyright Center for Virology and Vaccine Research. All rights reserved. Site by Academic Web Pages

Login